Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)
- PMID: 37088371
- DOI: 10.1016/j.jaip.2023.04.008
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources